Inventor · disambiguated record
Marlon Carlos
Also filed as: CARLOS MARLON · CARLOS MARLON V
23 granted patents·11 pending applications·154 citations·filing 2000–2025
96Inventor score
Top patents by PatentIndex Score
34 records- 0197US11091435B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P1 receptor-associated disordersARENA PHARM INC·Filed 2020·Granted Aug 17, 2021·11 cites·15 claims
- 0297US10676435B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2019·Granted Jun 9, 2020·12 cites·25 claims
- 0396US11884626B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disordersARENA PHARM INC·Filed 2021·Granted Jan 30, 2024·3 cites·16 claims
- 0494US10981870B2Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic formACADIA PHARM INC·Filed 2020·Granted Apr 20, 2021·5 cites·12 claims
- 0594US10981871B2Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form CACADIA PHARM INC·Filed 2020·Granted Apr 20, 2021·5 cites·13 claims
- 0693US10597363B2Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form CACADIA PHARM INC·Filed 2016·Granted Mar 24, 2020·10 cites·15 claims
- 0793US10301262B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2016·Granted May 28, 2019·11 cites·50 claims
- 0892US11827600B2Crystalline forms of trofinetideACADIA PHARM INC·Filed 2022·Granted Nov 28, 2023·3 cites·19 claims
- 0992US9353064B2Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related theretoARENA PHARM INC·Filed 2015·Granted May 31, 2016·9 cites·51 claims
- 1091US9034911B2Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related theretoSELVEY LEE ALANI·Filed 2009·Granted May 19, 2015·27 cites·58 claims
- 1190US12378198B2Crystalline l-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2023·Granted Aug 5, 2025·0 cites·40 claims
- 1289US8299241B2Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereofGHARBAOUI TAWFIK·Filed 2007·Granted Oct 30, 2012·18 cites·66 claims
- 1389US2025346560A1Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in sipi receptor-associated disordersARENA PHARM INC·Filed 2025·Application pending·0 cites
- 1488US9745270B2Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related theretoARENA PHARM INC·Filed 2016·Granted Aug 29, 2017·5 cites·8 claims
- 1587US10071075B2Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related theretoARENA PHARM INC·Filed 2017·Granted Sep 11, 2018·4 cites·34 claims
- 1686US10117851B2Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2017·Granted Nov 6, 2018·4 cites·22 claims
- 1785US9801856B2Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2015·Granted Oct 31, 2017·4 cites·28 claims
- 1884US9126946B2Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related theretoCARLOS MARLON·Filed 2009·Granted Sep 8, 2015·8 cites·66 claims
- 1984US7425630B2Processes for preparing pyrazolo[3,4-d]pyrimidine ethersARENA PHARM INC·Filed 2006·Granted Sep 16, 2008·14 cites·74 claims
- 2078US10583122B2Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2018·Granted Mar 10, 2020·1 cites·27 claims
- 2175US2022160681A1Composition of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2021·Application pending·0 cites
- 2273US12492167B2Crystalline forms of trofinetideACADIA PHARM INC·Filed 2023·Granted Dec 9, 2025·0 cites·39 claims
- 2372US2020138784A1Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related theretoARENA PHARM INC·Filed 2019·Application pending·0 cites
- 2471US11840515B2Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form cACADIA PHARM INC·Filed 2021·Granted Dec 12, 2023·0 cites·17 claims
- 2569US2020397753A1Composition of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2020·Application pending·0 cites
- 2666US10543193B2Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related theretoARENA PHARM INC·Filed 2018·Granted Jan 28, 2020·0 cites·38 claims
- 2748US2005261261A1Eplerenone drug substance having high phase purityPHARMACIA CORP·Filed 2005·Application pending·0 cites
- 2843US2005159594A1Eplerenone crystal form exhibiting enhanced dissolution ratePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2942US8822727B2Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepineCARLOS MARLON V·Filed 2009·Granted Sep 2, 2014·0 cites·29 claims
- 3042US2003083493A1Eplerenone drug substance having high phase purityFiled 2002·Application pending·0 cites
- 3141US2005267302A1Eplerenone crystalline form exhibiting enhanced dissolution rateSEARLE & CO·Filed 2003·Application pending·0 cites
- 3238US2005272927A1Process for the preparation of 9, 11 epoxy steroidsPHARMACIA & UPJOHN CO LLC·Filed 2005·Application pending·0 cites
- 3334US2002045746A1Eplerenone crystalline formFiled 2000·Application pending·0 cites
- 3434US2002038021A1Eplerenone crystalline form exhibiting enhanced dissolution rateFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marlon Carlos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →